Zobrazeno 1 - 2
of 2
pro vyhledávání: '"347"'
Autor:
Sung Bum Kang, Hye Seung Lee, Ji H. Kwon, Keun-Wook Lee, Kyoung Un Park, Jae Sung Kim, Duck-Woo Kim, Jee Hyun Kim, Jong Seok Lee, Mi Jung Kim, Jeong Ok Lee, Soo Mee Bang, Yu Jung Kim
Publikováno v:
BMC Cancer
BMC Cancer, Vol 12, Iss 1, p 347 (2012)
BMC Cancer, Vol 12, Iss 1, p 347 (2012)
Background We evaluated the association between a KRAS mutational status and various clinicopathologic features including the metastatic pattern in patients with metastatic or recurrent colorectal cancer (MRCRC). The concordance rates of the KRAS sta
Autor:
Marc Ychou, Jean-Nicolas Vaillant, Christine Boyer-Gestin, Jean-Baptiste Bachet, Céline Lepère, Philippe Rougier, Eric Assenat, Astrid Lièvre, Emmanuel Mitry, Emmanuelle Samalin, Fabienne Portales
Publikováno v:
BMC Cancer
BMC Cancer, Vol 9, Iss 1, p 347 (2009)
BMC Cancer, Vol 9, Iss 1, p 347 (2009)
Background The anti-VEGF antibody bevacizumab associated with an irinotecan or oxaliplatin-based chemotherapy was proved to be superior to the chemotherapy alone in first or second line treatment of metastatic colorectal cancer (mCRC). However, it wa